loading
Precedente Chiudi:
$3.00
Aprire:
$3.01
Volume 24 ore:
79,481
Relative Volume:
2.74
Capitalizzazione di mercato:
$9.69M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-1.4112
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
+0.00%
1M Prestazione:
+0.80%
6M Prestazione:
+12.69%
1 anno Prestazione:
-7.93%
Intervallo 1D:
Value
$2.90
$3.14
Intervallo di 1 settimana:
Value
$2.90
$3.70
Portata 52W:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
Nome
Cyclerion Therapeutics Inc
Name
Telefono
617-621-7722
Name
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Name
Dipendente
1
Name
Cinguettio
@Cyclerion
Name
Prossima data di guadagno
2024-12-15
Name
Ultimi documenti SEC
Name
CYCN's Discussions on Twitter

Confronta CYCN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
3.02 10.68M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-10-20 Iniziato Truist Buy
2021-09-24 Iniziato Cantor Fitzgerald Overweight
2019-06-03 Iniziato Credit Suisse Neutral

Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie

pulisher
Jul 24, 2025

How Cyclerion Therapeutics Inc. stock reacts to Fed policy changesExceptional ROI - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Cyclerion Therapeutics Inc. stock priceStrong return on assets - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Diana Tea Company Limited (530959) Signs Major DealFree Consultation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Cyclerion Therapeutics Inc. Stock Analysis and ForecastExceptional profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Cyclerion Therapeutics Inc. a good long term investmentMarket-crushing stock picks - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives NPWR.WS stock priceAccelerated earnings growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

HDLB Stock Analysis and ForecastPhenomenal capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Robin Energy Ltd. Stock Analysis and ForecastRapid growth opportunities - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about Cyclerion Therapeutics Inc. stockRapid return acceleration - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

HSPO Stock Analysis and ForecastFree Consultation - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about ADIL stockDynamic capital growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is GTSG a good long term investmentFree Wealth Planning Blueprint - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

ENTO Stock Analysis and ForecastUnprecedented profits - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Columbus McKinnon Corporation a good long term investmentConsistent triple returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Is DBVT a good long term investmentUnprecedented profits - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

How Cyclerion Therapeutics Inc. stock performs during market volatilityGrowth Stock Monitor - beatles.ru

Jul 18, 2025
pulisher
Jul 16, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Trading Down 3.6% – Time to Sell? - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Cyclerion Therapeutics Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

FIB(fib)Low Risk Stock Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Cyclerion Therapeutics Inc. stock price move sharplySmart Return Focused Trading - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes PotlatchDeltic Corporation stock price move sharplyFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How United Parcel Service Inc. stock performs during market volatilityFree VIP Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Sight Sciences Inc. stock price move sharply2x Return Forecast - Newser

Jul 15, 2025
pulisher
Jun 24, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Stock Price Down 2.4% – Here’s Why - Defense World

Jun 24, 2025
pulisher
Jun 18, 2025

Cyclerion Therapeutics Gains Shareholder Support at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
May 31, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Trading 6.5% Higher – Time to Buy? - Defense World

May 31, 2025
pulisher
May 30, 2025

Regina Graul, Ph.D., Promoted to Chief Executive Officer - marketscreener.com

May 30, 2025
pulisher
May 28, 2025

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire

May 28, 2025
pulisher
May 09, 2025

Renaissance Technologies LLC Invests $34,000 in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) - Defense World

May 09, 2025

Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):